Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3452621000168116 | Buprenorphine/Naloxone 5.7/1.4 (MPL) (buprenorphine 5.7 mg + naloxone 1.4 mg) sublingual tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3452631000168118 | Buprenorphine/Naloxone 5.7/1.4 (MPL) sublingual tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Buprenorphine/Naloxone 5.7/1.4 (MPL) sublingual tablet, 30 | Is a | buprenorphine 5.7 mg + naloxone 1.4 mg sublingual tablet, 30 | true | Inferred relationship | Some | ||
| Buprenorphine/Naloxone 5.7/1.4 (MPL) sublingual tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Buprenorphine/Naloxone 5.7/1.4 (MPL) sublingual tablet, 30 | has TPUU | Buprenorphine/Naloxone 5.7/1.4 (MPL) sublingual tablet | true | Inferred relationship | Some | 1 | |
| Buprenorphine/Naloxone 5.7/1.4 (MPL) sublingual tablet, 30 | has TP | Buprenorphine/Naloxone 5.7/1.4 (MPL) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Buprenorphine/Naloxone 5.7/1.4 (MPL) sublingual tablet, 30, blister pack | Is a | True | Buprenorphine/Naloxone 5.7/1.4 (MPL) sublingual tablet, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR